Asymmetric dimethylarginine – a marker of repeated cardiovascular events in patients with comorbid pathology
Abstract
Annotation. Today, diseases of the cardiovascular system retain their leading position among the incidence in the world. The presence of comorbid pathology in the form of type 2 diabetes mellitus (DM) significantly complicates the course of these diseases, worsening its prognosis. The aim of the study: to analyze the prognostic value of asymmetric dimethylarginine (ADMA) as a marker of recurrent cardiovascular events in patients with acute myocardial infarction with type 2 diabetes for 6 months of follow-up. 120 patients were examined: group 1 – patients with acute myocardial infarction (AMI) in combination with type 2 diabetes mellitus (n=70), group 2 - patients with isolated AMI (n=50). The control group included 20 practically healthy individuals. All patients underwent general clinical and instrumental examinations, on the first day of AMI the level of ADMA was determined using a commercial test system "Human Asymmetrical Dimethylarginine ELISA". Statistical processing of the obtained data was performed using the software package StatSoft Inc, USA – "Statistica 6.0". The analysis of the average level of ADMA showed a significantly higher value of this indicator in patients with AMI in combination with type 2 DM than in patients without concomitant type 2 DM 2.57 times (1.57±0.11 μmol / l and 0.61±0.06 μmol / l, respectively), (p<0,05. ADMA level >1,72 μmol / l in patients with AMI in combination with type 2 DM and >0,69 μmol / l in patients with AMI without concomitant type 2 DM was identified as a predictor of recurrent acute myocardial infarction within 6 months of follow-up. Thus, the level of ADMA was higher in the presence of comorbid pathology in the form of type 2 DM in patients with AMI, reflecting endothelial dysfunction combining disease. It is advisable to further study this indicator of endothelial dysfunction as a predictor of the adverse course of AMI in combination with concomitant type 2 DM.
Downloads
References
[2] Bora, S., & Shankarrao, P. (2021). Carbonyl stress in diabetics with acute coronary syndrome. Clin Chim Acta, 520, 78-86. doi: 10.1016/j.cca.2021.06.002
[3] Csiszar, B., Marton, Z., Riba, J., Csecsei, P., Nagy, L., Toth, K., … & Molnar, T. (2021). L-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study. Intern Emerg Med., Jun 3. doi: 10.1007/s11739-021-02767-z
[4] Dedov, I. I., Shestakova, M. V., & Galstyan, G. R. (2015). Алгоритмы специализированной медицинской помощи больным сахарным диабетом [Algorithms for specialized medical care for patients with diabetes mellitus]. Сахарный диабет – Diabetes mellitus, 18(1S), 1-112.
[5] Delano, M. J., & Ward, P. A. (2016). The immune system's role in sepsis progression, resolution, and long-term outcome. Immunol Rev., 274(1), 330-353. doi: 10.1111/imr.12499
[6] Fleischmann, C., Thomas-Rueddel, D. O., Hartmann, M., Hartog, C. S., Welte, T., Heublein, S., … & Reinhart, K. (2016). Hospital incidence and mortality rates of sepsis. Dtsch Arztebl Int., 113(10), 159-166. doi: 10.3238/arztebl.2016.0159
[7] Goff, D. C., Lioyd-Jones, D. M., Bennett, G., Coady, S., D'Agostino Sr, R. B., Gibbons, R. … & Wilson, P. W. F. (2014). 2013 ACCAHA Guideline on the Assessment of Cardiovascular Risk. J Am Coll Cardiol., 63(25), 2935-2959. doi: 10.1016/j.jacc.2013.11.005
[8] Hannemann, J., Appel, D., Seeberger-Steinmeister, M., Brüning, T., Zummack, J., & Böger, R. (2020). Sequence Variation in the DDAH1 Gene Predisposes for Delayed Cerebral Ischemia in Subarachnoidal Hemorrhage. J Clin Med., 9(12), 3900. doi: 10.3390/jcm9123900
[9] Kantae, V., Krekels, E. H. J., Van Esdonk, M. J., Lindenburg, P., Harms, A. C., Knibbe, C. A. J., … & Hankemeier, T. (2017). Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: Towards personalized drug therapy: An addition to the topical collection “Recent Advances in Pharmacometabolomics: Enabling Tools for Precision Medicine”. Metabolomics, 13. doi: 10.1007/s11306-017-1189-8
[10] Keller, A., Becker, C., Nienhaus, K., Beck, K., Vincent, A., Sutter, R., … & Hunziker, S. (2020). Arginine and Arginine/ADMA Ratio Predict 90-Day Mortality in Patients with Out-of-Hospital Cardiac Arrest-Results from the Prospective, Observational COMMUNICATE Trial. J Clin Med., 9(12), 3815. doi: 10.3390/jcm9123815
[11] Kornienko, E. A., Oynotkinova, O. Sh., Baranov, A. P., Goncharova, E. I., & Ivanov, D. V. (2015) Современные взгляды на єтиопатогенез инфаркта миокарда при сахарном диабете 2 типа и методы лечения [Modern views on the thyopathogenesis of myocardial infarction in type 2 diabetes mellitus and methods of treatment]. Вестник новых медицинских технологий – Bulletin of new medical technologies, 2, 3-8.dоі: 10.12737/11912
[12] Li, Q., Chen, Y., Li, B., Luo, C., Zuo, S., Liu, X., … & Feng, H. (2016). Hemoglobin induced NO/cGMP suppression Deteriorate Microcirculation via Pericyte Phenotype Transformation after Subarachnoid Hemorrhage in Rats. Sci. Rep., 6, 22070. doi: 10.1038/srep22070
[13] Menshikova, I. G., Loskutova, N. V., Sklyar, I. V., Lеvanova, T. V., & Mironova, O. A. (2015). Клиника, диагностика, принципы лечения с основами физической реабилитации больных острым инфарктом миокарда [Clinic, diagnostics, principles of treatment with the basics of physical rehabilitation of patients with acute myocardial infarction]. Благовещенск: Амурская ГМА – Blagoveshchensk: Amur State Medical Academy.
[14] Németh, B., Kustán, P., Németh, A., Lenkey, Z., Cziráki, A., Kiss, I., … & Ajtay, Z. (2016). Asymmetric dimethylarginine: predictor of cardiovascular diseases? Orv Hetil. Article in Hu, 157(13), 483-7. doi: 10.1556/650.2016.30396
[15] Nickler, M., Ottiger, M., Steuer, C., Huber, A., Anderson, J. B., Muller, B., & Schuetz, P. (2015). Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir. Res., 16, 125. doi: 10.1186/s12931-015-0283-6
[16] Panchal, A. R., Bartos, J. A., Cabañas, J. G., Donnino, M. W., Drennan, I. R., Hirsch, K. G., … & Berg, K. M. (2020). Part 3: adult basic and advanced life support: 2020 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation, 142(16, 2), 366-468. doi: 10.1161/CIR.0000000000000916
[17] Sandroni, C., Grippo, A., & Nolan, J. P. (2020). ERC-ESICM guidelines for prognostication after cardiac arrest: time for an update. Intensive Care Med., 46(10), 1901-1903. doi: 10.1007/s00134-020-06224-x
[18] Schlesinger, S., Sonntag, S. R., Lieb, W., & Maas, R. (2016). Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: A systematic review and meta-analysis of prospective studies. PLoS ONE, 11(11). doi: 10.1371/journal.pone.0165811
[19] Schluep, M., Gravesteijn, B. Y., Stolker, R. J., Endeman, H., & Hoeks, S. E. (2018). One-year survival after in-hospital cardiac arrest: a systematic review and meta-analysis. Resuscitation, 132, 90-100. doi: 10.1016/j.resuscitation.2018.09.001
[20] Schmitt, V., Leuschner, A., Jünger, C., Pinto, A., Hahad, O., Schulz, A., … & Münzel, T. (2021). Cardiovascular profiling in the diabetic continuum: results from the population-based Gutenberg Health Study. Clin Res Cardiol., 2021. doi: 10.1007/s00392-021-01879-y
[21] Strobel, J., Müller, F., Zolk, O., Endress, B., König, J., Fromm, M. F., … & Maas, R. (2013). Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1). Amino Acids, 45(4), 989-1002. doi: 10.1007/s00726-013-1556-3
[22] Vallance, P., Leone, A., Calver, A., Collier, J., & Moncada, S. (1992). Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 339(8793), 572-5. doi: 10.1016/0140-6736(92)90865-z
[23] Winkler, M., Nierhaus, A., Rösler, G., Lezius, S., Harlandt, O., Schwedhelm, E., … & Kluge, S. (2018). Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival. Critical Care, 22(1), 216. doi: 10.1186/s13054-018-2090-1
[24] Yan, S., Gan, Y., & Jiang, N. (2020). The global survival rate among adult out-of-hospital cardiac arrest patients who received cardiopulmonary resuscitation: a systematic review and meta-analysis. Crit Care, 24(1), 61. doi: 10.1186/s13054-020-2773-2
[25] Zhang, H., Chen, J., Chen, С., Wan, Н., Chen, Y., Wang, Y., … & Lu, Y. (2021). Exposure to phthalates and cardiovascular diseases in Chinese with type 2 diabetes. Environ Sci Pollut Res Int., 28(41):58113-58122. doi: 10.1007/s11356-021-14807-4
This work is licensed under a Creative Commons Attribution 4.0 International License.